Patent broker fees and minimums: what do brokers charge, and why do they decline most patents?

The contingency model aligns the broker's interest with the owner's: no sale, no fee. It also explains the screening that follows. A broker who is paid only when a package sells has to spend unpaid time on every package it takes, so it takes the ones it expects to sell. That is the single most useful fact for an owner to understand about broker economics, and it is why a decline says more about fit than about the invention.

The published ranges below are wide because the work varies. A large portfolio with evidence of use and a known buyer pool needs less marketing than a small family in a new field, and the share a broker asks tends to follow the work it expects to do. Ask any broker what its share covers, what base it is calculated on, and what it bills separately.

Claim charts and evidence of use are the items most often billed separately, and they are also the items buyers say matter most. An owner who arrives with them is easier to place and, on the buyer panel's account, more likely to be taken seriously. An owner who does not have them should ask who will prepare them, under whose direction, and at whose cost, before signing anything.

Maintenance fees stay with the owner through any sale process. A process that runs across a fee window means paying the fee, and a patent that lapses in the middle of a process is worth nothing to the buyer. Know your windows before you list.

The two lines measure different things. A broker's threshold is about whether the expected fee justifies the broker's time. A buyer's floor is about whether the deal justifies the buyer's internal cost: legal review, engineering review, business approval, and the negotiation itself. A buyer's floor is usually the harder of the two, because no amount of marketing moves it.

For an owner with a single patent, the practical reading is simple. If the honest value of the asset sits below both lines, the broker route and the large-buyer route are both closed for a sale of that asset alone, whatever its technical merit. The routes that stay open are a different buyer, a different deal shape, or a package that combines the patent with something a buyer values more, such as a field-limited license or a product partnership.

The sales-rate figures below are dated and measure different windows, so they are not a forecast for this year. What they show consistently is that a listing is not a sale, and that a broker who took every package offered would spend most of its time on packages that never close. Screening hard is how brokers stay in business, which is why the decline rate is high in every source we found.

The reasons a broker declines are usually concrete: no evidence that anyone practices the claims, a short remaining term, gaps in the chain of title, claims a buyer could design around, a single patent with no family behind it, or a price expectation the market has not shown. Each one is worth knowing, because several can be fixed before the next approach.

Exclusivity protects a broker that is spending unpaid time, and a reasonable broker will ask for it. The cost to the owner is time: if the listing does not produce a buyer, the patent's remaining life and the next maintenance window keep running while the owner waits for the term to end.

The tail is the term owners most often miss. If a buyer the broker contacted comes back after the engagement ends, the broker usually still earns its share for a stated period. That is fair for buyers the broker found. It is worth negotiating for buyers the owner already knew, which should be listed by name, in writing, before the engagement starts.

A fixed-price program is a real exit with a published process, and it suits an owner who wants a clean sale at a price it sets. The program acts for its members, not the seller, so it will not argue for a higher price, and an owner who prices above what the members will pay simply does not sell.

A direct approach suits an owner who already knows which company needs the patent. The broker's value is buyer access and process. Where the owner already has the access, what it needs is the process: a thesis test, a package written for that buyer, a route to the person who owns the problem, and counsel ready to close.

This matters for fees because it changes what an owner is paying for. A broker's share buys buyer access and process. Claim charts and evidence of use, which buyers say move decisions, are usually a separate cost whoever prepares them. An owner comparing routes should compare what each delivers against what buyers say they need, not the headline percentage alone.

Changing the asset means adding what buyers ask for: evidence of use prepared under counsel's direction, a clean chain of title, and, where counsel says it is still possible, a continuation that gives a buyer more than one claim set. Changing the buyer means looking past the largest companies to the ones whose product the claims fit most closely, which may be smaller and may have no floor at all. Changing the deal shape means offering a field-limited or non-exclusive license where a sale would not clear anyone's line.

None of those steps needs a broker, and all of them make an asset easier for a broker to place later if the owner still wants a sale.

Patenture takes the owners brokers pass on: single patents, assets below a broker's threshold, and owners who want a licensing program rather than a sale.

For an owner who already knows the buyer, the work starts with the Mandate Review: about a week, ending in a thesis test, a deal shape, the diligence gaps, and a written yes or no on whether we take the mandate. The Licensing and Sale Mandate follows where the answer is yes, with patent counsel drafting and closing.